Chad Cowan - 18 Sep 2025 Form 4 Insider Report for Century Therapeutics, Inc. (IPSC)

Role: Chief Scientific Officer
Signature: /s/ Douglas Carr, Attorney-in-Fact
Issuer symbol: IPSC
Transactions as of: 18 Sep 2025
Net transactions value: $0
Form type: 4
Filing time: 22 Sep 2025, 16:56:33 UTC
Previous filing: 12 Mar 2025
Next filing: 24 Nov 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Cowan Chad	Chief Scientific Officer	C/O CENTURY THERAPEUTICS, INC., 25 N 38TH STREET, 11TH FLOOR, PHILADELPHIA	/s/ Douglas Carr, Attorney-in-Fact	22 Sep 2025	0002039294

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	IPSC	Common Stock	Award	$0	+762,543	+332%	$0.000000	992,489	18 Sep 2025	Direct	F1
holding	IPSC	Common Stock						10,697	18 Sep 2025	By Trust	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Issuer common stock. The RSUs vest 50% on October 1, 2026, with the remaining 50% vesting on October 1, 2027, in each case subject the Reporting Person's continued service through the applicable vesting date. The RSUs will be settled on each applicable vesting date in shares of the Issuer's common stock.
F2	Shares held by the Cowan Investment Nominee Trust. The Reporting Person disclaims beneficial ownership except to the extent of any pecuniary interest therein, and this report shall not be deemed an admission that such shares are beneficially owned by him for Section 16 or any other purpose.

Content

Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Issuer common stock. The RSUs vest 50% on October 1, 2026, with the remaining 50% vesting on October 1, 2027, in each case subject the Reporting Person's continued service through the applicable vesting date. The RSUs will be settled on each applicable vesting date in shares of the Issuer's common stock.

Shares held by the Cowan Investment Nominee Trust. The Reporting Person disclaims beneficial ownership except to the extent of any pecuniary interest therein, and this report shall not be deemed an admission that such shares are beneficially owned by him for Section 16 or any other purpose.